조영제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 시술별(X선/컴퓨터 단층촬영, 자기공명영상, 초음파), 적응증별, 지역별 및 경쟁별 세분화(2020-2030년)

The Global Contrast Media Market, valued at USD 5.07 Billion in 2024, is projected to experience a CAGR of 4.30% to reach USD 6.53 Billion by 2030. Contrast media are pharmaceutical agents administered to patients to improve the visualization of internal structures, blood vessels, and tissues during medical diagnostic imaging procedures such as X-rays, computed tomography, magnetic resonance imaging, and ultrasound. The market's growth is primarily driven by the increasing global prevalence of chronic diseases, including cardiovascular conditions and various cancers, necessitating precise diagnostic evaluations.

Key Market Drivers

The rising global burden of chronic diseases significantly drives the demand for contrast media, as accurate and timely diagnosis is paramount for effective patient management. Conditions such as various cancers, cardiovascular disorders, and neurological diseases increasingly necessitate advanced imaging procedures for detection, staging, and monitoring disease progression. This escalating prevalence inherently expands the volume of diagnostic interventions requiring contrast enhancement, thereby directly increasing the consumption of these agents.

Key Market Challenges

The primary challenge impeding the growth of the Global Contrast Media Market is stringent regulatory requirements and the complex, lengthy approval processes for new contrast agents. These hurdles significantly delay product introduction and escalate development costs. The rigorous scrutiny and extensive documentation demanded for market authorization prolong the research and development phase, directly affecting market expansion.

Key Market Trends

AI integration is significantly optimizing the utility of contrast media by enhancing diagnostic imaging workflows. AI algorithms improve efficiency and diagnostic accuracy in tasks such as intelligent scan protocoling, critical case prioritization, and automated image analysis. By December 2024, the U. S. Food and Drug Administration had cleared approximately 1,000 clinical AI algorithms, with nearly 80% specifically for medical imaging, as reported by the Radiological Society of North America.

Key Market Players

• Bayer AG
• Bracco Diagnostic Inc. (Bracco Group)
• GE Healthcare Technologies Inc.
• Guerbet Group
• Lantheus Medical Imaging Inc
• Spago Nanomedical AB
• FUJIFILM Holdings Corporation
• Beijing Beilu Pharmaceutical Company Limited
• TAEJOON Pharmaceutical Co., Ltd.

Report Scope:

In this report, the Global Contrast Media Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contrast Media Market, By Type:

• Iodinated Contrast Media
• Gadolinium-based Contrast Media
• Microbubble Contrast Media
• Barium-based Contrast Media

Contrast Media Market, By Procedure:

• X-ray/Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound

Contrast Media Market, By Indication:

• Cardiovascular Disease
• Oncology
• Gastrointestinal Disorders
• Neurological Disorders
• Other Indications

Contrast Media Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Media Market.

Available Customizations:

Global Contrast Media Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contrast Media Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media)
  • 5.2.2. By Procedure (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound)
  • 5.2.3. By Indication (Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, Other Indications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Contrast Media Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Procedure
  • 6.2.3. By Indication
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contrast Media Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Procedure
      • 6.3.1.2.3. By Indication
  • 6.3.2. Canada Contrast Media Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Procedure
      • 6.3.2.2.3. By Indication
  • 6.3.3. Mexico Contrast Media Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Procedure
      • 6.3.3.2.3. By Indication

7. Europe Contrast Media Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Procedure
  • 7.2.3. By Indication
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Contrast Media Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Procedure
      • 7.3.1.2.3. By Indication
  • 7.3.2. France Contrast Media Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Procedure
      • 7.3.2.2.3. By Indication
  • 7.3.3. United Kingdom Contrast Media Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Procedure
      • 7.3.3.2.3. By Indication
  • 7.3.4. Italy Contrast Media Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Procedure
      • 7.3.4.2.3. By Indication
  • 7.3.5. Spain Contrast Media Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Procedure
      • 7.3.5.2.3. By Indication

8. Asia Pacific Contrast Media Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Procedure
  • 8.2.3. By Indication
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contrast Media Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Procedure
      • 8.3.1.2.3. By Indication
  • 8.3.2. India Contrast Media Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Procedure
      • 8.3.2.2.3. By Indication
  • 8.3.3. Japan Contrast Media Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Procedure
      • 8.3.3.2.3. By Indication
  • 8.3.4. South Korea Contrast Media Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Procedure
      • 8.3.4.2.3. By Indication
  • 8.3.5. Australia Contrast Media Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Procedure
      • 8.3.5.2.3. By Indication

9. Middle East & Africa Contrast Media Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Procedure
  • 9.2.3. By Indication
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Contrast Media Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Procedure
      • 9.3.1.2.3. By Indication
  • 9.3.2. UAE Contrast Media Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Procedure
      • 9.3.2.2.3. By Indication
  • 9.3.3. South Africa Contrast Media Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Procedure
      • 9.3.3.2.3. By Indication

10. South America Contrast Media Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Procedure
  • 10.2.3. By Indication
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Contrast Media Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Procedure
      • 10.3.1.2.3. By Indication
  • 10.3.2. Colombia Contrast Media Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Procedure
      • 10.3.2.2.3. By Indication
  • 10.3.3. Argentina Contrast Media Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Procedure
      • 10.3.3.2.3. By Indication

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Contrast Media Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bayer AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bracco Diagnostic Inc. (Bracco Group)
• 15.3. GE Healthcare Technologies Inc.
• 15.4. Guerbet Group
• 15.5. Lantheus Medical Imaging Inc
• 15.6. Spago Nanomedical AB
• 15.7. FUJIFILM Holdings Corporation
• 15.8. Beijing Beilu Pharmaceutical Company Limited
• 15.9. TAEJOON Pharmaceutical Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer